Hypnopompic Hallucinations


Hypnopompic Hallucinations 

A dear patient of mine who I have known for years, came in yesterday stating, “I have been seeing things.” When I asked what do you mean, she proceeded to tell me about all the things she has been seeing right after “waking up”in the morning. She is a lovely woman and very sharp, so I listened intently on her pain of seeing many unusual things every morning and also during the day.

Before I could ask, “Did you see a neurologist? Did you get an MRI? What did it & the blood test show?” She said, “First let me tell you about all I have seen. I have seen a cat and dog doing the jig and talking to each other.”

I asked her if she could hear them talking and she said, “No. I just see their mouths moving.”

She continued. “I have seen a snake across my kitchen chair. He is still there. I have seen a very vicious dog sitting on top of my bed.”

I asked when this started. She said that a few months ago, she saw a strange dog in her kitchen. She thought it was real so she called the police and had someone come get the dog. When they arrived, they thought she was crazy, but for her, the dog was still there.

She ended up seeing a neurologist who ordered an MRI which showed small vessel changes in her cortex but not clear stroke. Her carotid ultrasound and doppler showed 50% stenosis. She does have high cholesterol and is on cholesterol medications. It is likely there are possible mini-strokes that could be the cause. Her EEG did not show any seizure activity. Her blood work was normal.

She shared with me how distressing this has been and how she has cried many nights afraid to go to bed. Poor thing! She said she was petrified to sleep because she was so scared to wake up.

She continued. She said, “After you did the laser iridotomy from my narrow angles awhile ago, I started seeing little mice run across the floor on both side.” I asked if they were floaters that moved around, which are not uncommon after a laser iridotomy. She said, “No. I know what floaters are. I’ve had them for years. These were not floaters. I saw what looked like real mice running along my floor on both sides.”

This is the first case reported of experiencing a hallucination after laser iridotomy in a patient with a history of Hypnopompic Hallucinations, which might be prompted by the small laser holes we make at the 9 o’clock for the right eye and 3 o’clock position for the left eye. It has since gone away but the whole experience has been very disconcerting as the other hallucinations continue.  Of note, she said, she recently went on a cruise with her daughter and they shared a room. Her daughter said that 6 of the 7 nights, this patient “talked up a storm all night long.” Thank goodness there is no tumor in her brain but there must be a way to stop these hallucinations for this patient.

In the research I did for her below. There is 1 case report of a young boy who had hallucinations and other symptoms who experienced a resolution in his symptoms by going on a Gluten Free Diet.

Thus for now, MDs will likely recommend:
1. Avoid stimulants, caffeine, etc.
2. Avoid smoking.
3. Avoid gluten
4. Avoid sugar
5. Medicines are the next tier of treatment & this is controversial given the lack of studies I could find. Your neurologist will need to review the benefits and alternatives of every option.

Sandra Lora Cremers, MD, FACS

Here is more information below.

For patients with this condition. Here are some resources that might help:
1. https://www.sleepassociation.org/patients-general-public/hallucinations-during-sleep/
2. http://neurocritic.blogspot.com/2013/12/when-waking-up-becomes-nightmare.html

The best MDs in the DC area to treat Hypnopompic Hallucinations are:

Johns Hopkins University:

Gamaldo, Charlene Edie, M.D.

Associate Professor of Neurology
Associate Professor of Anesthesiology and Critical Care Medicine
Joint Appointment in Psychiatry and Behavioral Sciences
Medical Director, Johns Hopkins Sleep Disorders Center
Appointment Phone: 800-937-5337
Main Location: Howard County General Hospital Sleep Lab
Expertise, Disease and Conditions: Neurology, Sleep Apnea, Sleep Disorders, Sleep Medicine, Snoring Disorders

Photo of Dr. Charlene Edie Gamaldo, M.D.

Photo of Dr. Cynthia Melinda Boyd, M.D., M.P.H.

Boyd, Cynthia Melinda, M.D., M.P.H.

Associate Professor of Medicine
Appointment Phone: 410-550-0925
Main Location: Johns Hopkins Bayview Medical Center
Expertise, Disease and Conditions: Cognitive Decline in Older Adults, General Internal Medicine, Geriatric Consultation and Preventative Health, Geriatric Medicine, Osteoporosis, Paget’s Disease…More
Photo of Dr. Dejan B. Budimirovic, M.D.

Budimirovic, Dejan B., M.D.

Assistant Professor of Psychiatry and Behavioral Sciences
Attending Psychiatrist, NBU and Outpatient Child & Adolescent Psychiatry
Main co-Investigator, Clinical Trials Unit, Kennedy Krieger Institute
Medical co-Director, Fragile X Clinic
Photo of Dr. John R Burton, M.D.

Burton, John R, M.D.

Professor of Medicine
Director, Johns Hopkins Geriatric Education Center
Appointment Phone: 410-550-0925
Main Location: Johns Hopkins Bayview Medical Center
Expertise, Disease and Conditions: Arthritis, Aspiration Pneumonia, Cognitive Decline in Older Adults, Constipation, Dizziness, Eldercare, General Internal Medicine…More
Photo of Dr. Christopher J Earley, M.B.B.Ch., Ph.D.

Earley, Christopher J, M.B.B.Ch., Ph.D.

Professor of Neurology
Appointment Phone: 410-550-0571
Main Location: Johns Hopkins Bayview Medical Center
Expertise, Disease and Conditions: Circadian Rhythm Disorders, Insomnia, Narcolepsy, Neurology, Restless Legs Syndrome, Sleep Apnea, Sleep Disorders, Sleep Medicine
Photo of Dr. Thomas Finucane, M.D.

Finucane, Thomas, M.D.

Professor of Medicine
Co-director, Elder House Call Program, Johns Hopkins Bayview Medical Center
Appointment Phone: 410-550-0925
Main Location: Johns Hopkins Bayview Medical Center
Expertise, Disease and Conditions: Alzheimer’s Disease (AD), Aspiration Pneumonia, Clinical Care of Older Adults, Cognitive Decline in Older Adults, Geriatric Medicine, Palliative Care, Polypharmacy…More
Photo of Dr. Charlene Edie Gamaldo, M.D.

Gamaldo, Charlene Edie, M.D.

Associate Professor of Neurology
Associate Professor of Anesthesiology and Critical Care Medicine
Joint Appointment in Psychiatry and Behavioral Sciences
Medical Director, Johns Hopkins Sleep Disorders Center
Appointment Phone: 800-937-5337
Main Location: Howard County General Hospital Sleep Lab
Expertise, Disease and Conditions: Neurology, Sleep Apnea, Sleep Disorders, Sleep Medicine, Snoring Disorders
Photo of Dr. James C Harris, M.D.

Harris, James C, M.D.

Professor of Psychiatry and Behavioral Sciences
Joint Appointment in History of Medicine
Professor of Pediatrics
Director, Developmental Neuropsychiatry Clinic
Appointment Phone: 410-614-2401
Main Location: The Johns Hopkins Hospital
Expertise, Disease and Conditions: Adult Psychiatry, Child and Adolescent Psychiatry, Child Development and Behavioral Health, Lesch-Nyhan Disease, Neurodevelopmental Disorders, Psychiatry
Photo of Dr. Abbey Jean Hughes, M.A., Ph.D.

Hughes, Abbey Jean, M.A., Ph.D.

Assistant Professor of Physical Medicine and Rehabilitation
Appointment Phone: 410-614-4030
Main Location: The Johns Hopkins Hospital (Main Entrance)
Expertise, Disease and Conditions: Adjustment to Chronic Illness, Behavioral Sleep Medicine, Chronic Disease Management, Chronic Pain, Cognitive Rehabilitation, Multiple Sclerosis…More
Photo of Dr. Jonathan Jun, M.D.

Jun, Jonathan, M.D.

Assistant Professor of Medicine
Appointment Phone: 443-287-3313
Main Location: Johns Hopkins Outpatient Center
Expertise, Disease and Conditions: Critical Care Medicine, Pulmonary and Critical Care Medicine, Pulmonary Medicine, Sleep Disorders

References:

ARTICLE
Nature Neuroscience  1, 738 – 742 (1998)
doi:10.1038/3738


The anatomy of conscious vision: an fMRI study of visual hallucinations

D. H. ffytche, R. J. Howard, M. J. Brammer, A. David, P. Woodruff & S. Williams

Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK


Correspondence should be addressed to D. H. ffytche d.ffytche@iop.bpmf.ac.uk

Despite recent advances in functional neuroimaging, the apparently simple question of how and where we see—the neurobiology of visual consciousness—continues to challenge neuroscientists. Without a method to differentiate neural processing specific to consciousness from unconscious afferent sensory signals, the issue has been difficult to resolve experimentally. Here we use functional magnetic resonance imaging (fMRI) to study patients with the Charles Bonnet syndrome, for whom visual perception and sensory input have become dissociated. We found that hallucinations of color, faces, textures and objects correlate with cerebral activity in ventral extrastriate visual cortex, that the content of the hallucinations reflects the functional specializations of the region and that patients who hallucinate have increased ventral extrastriate activity, which persists between hallucinations.

Few imaging studies have investigated the conscious ‘pictures’ of the external environment that we associate with seeing (visual percepts). The problem that confronts the neuroscientist is recognizing the neural correlate of ‘seeing’ and differentiating it from afferent sensory activity, which is assumed to remain unconscious1. One solution is to study a visual system in which percepts have become dissociated from sensory input. Such dissociation can follow a sudden deterioration in visual abilities in patients who in other respects are neuropsychiatrically normal2, 3, 4. This syndrome is termed the Charles Bonnet syndrome (named after the Swiss philospher who first described it)5. The spontaneous visual percepts (visual hallucinations) experienced by these patients are identical to those associated with normal seeing, although they can be recognized because of their bizarre and often amusing character and because, given the patients’ impaired vision, they are seen in greater detail than real stimuli6. They differ from visual imagery experiences in that the hallucinations are localized to external space (rather than inside the head), have the vivid qualities of normal seeing and are not under voluntary control. We investigated the neural substrate of visual consciousness in a group of such patients, using two different but complimentary strategies, both of which have proven successful previously7, 8, 9.


The first strategy (Experiment 1) was to ask the patients to signal the onset and offset of each hallucination during a five-minute scan and to then correlate the timing of the hallucinations with the time-course of the fMRI signal. A second, indirect strategy, which did not depend on capturing a hallucination during a scan, identified functionally abnormal brain regions by scanning the patients while they viewed a nonspecific visual stimulus and comparing the results to those of a matched control group who had never experienced hallucinations (Experiment 2).


RESULTS
Visual hallucinations were reported in both experiments. Four patients had spontaneous hallucinations, whereas two others had hallucinations provoked by visual stimulation (Table 1). With the exception of one patient (PP), all hallucinations were in color. Two patients (SH, LC) reported faces, two (FP, PP) reported brickwork, fencing and map textures, and one (AK) reported objects. Unless otherwise stated, all hallucinations occurred in the central visual field. In two patients (AK and FP), Experiment 1 was repeated within the same scanning session to assess response consistency. Three patients (SH, AK, FP) with spontaneous hallucinations were unable to see the stimulus and therefore did not participate in Experiment 2. Therefore, with the exception of one patient (PP), the two experiments had different subjects.


Table 1. The phenomenology and timing of visual hallucinations.
Table 1 thumbnail

Full TableFull Table

Spontaneous hallucinations
In all four patients with spontaneous hallucinations, the fMRI activity that correlated most significantly with the hallucination report was located in the ventral occipital lobe within or around the fusiform gyrus (Fig. 1). Colored hallucinations were associated with activity in the posterior fusiform gyrus (mean x = +28 and −35, y = −81, z = −13), whereas black-and-white hallucinations were associated with activity behind and above this region (x = 30, y = −84, z = −2). The hallucination of a face was associated with activity in the left middle fusiform gyrus (x = −42, y = −57, z = −7.5), hallucinations of objects were associated with activity in the right middle fusiform gyrus (x = 21, y = −66, z = −18), and hallucinations of textures were associated with activity around the collateral sulcus. In some experiments, additional activity was found outside ventral extrastriate cortex (for example, the frontal activation in patient FP or the activity on the medial occipital lobe in SH, shown in Fig. 1); however, this additional activity was neither consistent between repeated experiments in the same patient nor common among different patients. An increase in fMRI signal often preceded a hallucination (for example, the first, fourth and sixth hallucination shown in Fig. 2a). This temporal relationship was found in all patients studied (Fig. 2b).


Figure 1. Spontaneous hallucinations.
Figure 1 thumbnail
Positive correlations between T2*-weighted MRI signal and hallucination report are superimposed (red) on transverse sections of high-resolution structural images (rmax AK, p < 1 times 10−3 ; PP, FP, p < 1 times 10−4; SH, p < 1 times 10−5). The fusiform gyrus has been shaded in blue to aid anatomical localization. The hallucinations are illustrated next to each image. Ventral occipital activity was consistent in repeated experiments on the same patient. The r max was always in the ventral occipital lobe, but the optimal temporal shift varied between patients. No areas had a negative correlation at the same level of significance. In all figures, the left of each structural image is the right of the brain.

Full FigureFull Figure and legend (43K)

Figure 2. The timing of visual hallucinations.
Figure 2 thumbnail
(a) The fMRI time series from the fusiform gyrus (circles) and hallucination log (bars) for patient SH. (b) The mean signal intensity in the 12 seconds before and after the report of hallucination onset. Only hallucinations that occurred after a gap of at least 18 seconds have been included to avoid detecting the signal related to the previous hallucination (n = 13). MR signal has been normalized to the −15 s scan. The increase in signal in the 12 seconds preceding a hallucination is significant (F(4,60) = 3.83; p < 0.01).

Full FigureFull Figure and legend (6K)

Response to visual stimulation
In Experiment 2, in patients with impaired vision who had never hallucinated, the visual stimulus evoked activity along the calcarine fissure (area V1), extending onto the ventral surface of the occipital lobe to include the fusiform gyrus (Fig. 3a). In patients with the Charles Bonnet syndrome, this stimulus evoked activity in the striate cortex but failed to do so in the fusiform and lingual gyri (Fig. 3b). We compared the corrected mean level of fMRI signal (see Methods) within the active ventral extrastriate regions in the controls with the corresponding silent regions in the patients. Mean signal was increased significantly in the hallucinators relative to the controls across the whole five-minute experiment (t = 2.94, df = 8, p < 0.025). The apparent silence of the region was due to a relatively greater increase in signal between the periods of visual stimulation (OFF) than during stimulation (ON), with a consequent degradation of periodic signal (see Methods).


Figure 3. Generic activation to visual stimulation.
Figure 3 thumbnail
Voxels in phase with the stimulus are thresholded at p < 0.05, corrected for multiple comparisons, and superimposed (red) on transverse slices of a template structural image. Talairach z coordinates in mm above and below the AC−PC plane are displayed beneath each column. (a) Control patients. (b) Hallucinators.

Full FigureFull Figure and legend (25K)

 Top

DISCUSSION
Our two sets of results converge on a single conclusion, that hallucinations of color, faces, textures and objects result from increased activity in the ventral occipital lobe. A phasic increase in activity causes a discrete hallucination (Experiment 1), whereas a tonic increase in activity decreases the response to external visual stimulation (Experiment 2). An unexpected finding was the rise in fMRI signal before the onset of the conscious experience, the opposite of the normal delayed response to visual stimulation found in fMRI experiments10, 11. Patients described the appearance and disappearance of their hallucinations as sudden (< 1 s), all-or-nothing phenomena, so the observed ‘reversed’ delay is not an artifact of uncertainty as to when to report the experience. One explanation for this finding might be that cerebral activity must exceed a certain threshold level to contribute to visual consciousness12 and that subthreshold neurophysiological activity starting 15 seconds before the hallucination is responsible for the increase in signal found at −12 seconds.


We found a striking correspondence between the hallucinatory experiences of each patient and the known functional anatomy of the occipital lobe. In patients who hallucinated in color, activity was found in the fusiform gyrus in an area corresponding to the color center, area V4 (mean x = plusminus28, y = −79, z = −16, see Refs 13,14), whereas in the patient who hallucinated in black and white, the activity was outside this region (posterior extent of = −82, max z = −12, see ref 14). The descriptions of featureless colors in the hallucinations are similar to the descriptions given by patients whose ventro-medial occipital cortex has been stimulated directly15. In the patient who hallucinated an unfamiliar face, additional activity was found in the left middle fusiform gyrus, an area that responds to unfamiliar face stimuli (mean x = −35, y = −63, z = −10, see ref 16). In patients who hallucinated brickwork, fences and a map, activity was found around the collateral sulcus, an area that responds to visual textures11. Finally, in the patient who hallucinated objects, activity was found in the middle fusiform gyrus, an area that responds to visually presented objects17,18. These results are, to our knowledge, the first evidence of a correlation between the location of activity within specialized cortex and the contents of a hallucination. 


Visual hallucinations are difficult to dismiss as vivid imagery experiences, as they differ both qualitatively (see Introduction) and, at least for color hallucinations, neurobiologically. (Area V4 was not differentially activated in a color imagery task compared to a spatial-orientation control task19.) The neural substrate of a color hallucination is thus closer to that of a true (non-hallucinated) percept than that of color imagery. The areas identified are unlikely to be related to the motor signaling response of the patients, as this would occur at twice the hallucination frequency (patients signaled both the onset and the offset of each hallucination), and our correlation method would thus be relatively insensitive to it. The complexity of the percepts and the absence of consistent activity in the striate cortex make it unlikely that the ventral occipital lobe is responding to spontaneous discharges in the retina or LGN. Similarly, the absence of consistent activity outside the occipital lobe argues against the hypothesis that activity in the frontal lobe is a prerequisite for conscious vision1,20 or that visual complexity in hallucinations implies activity in the anteriolateral temporal lobe15. However, our data fall short of disproving such theories. If the spatial pattern of ‘higher’ activity is not fixed for a given perceptual experience or is so diffusely distributed that its activity is not reflected in a change in fMRI signal, it would not have been detected by our method. Visual consciousness is presumably the result of complex neuronal processes with top-down influences. The results presented above suggest that such top-down complexity may be localized within each specialized area rather than being distributed across the brain.


We conclude that in patients who are neuropsychiatrically normal and in the absence of afferent sensory input, conscious percepts of color, texture, faces and objects are associated with activity in the ventral extrastriate cortex reflecting the known functional specializations of the region. Why these particular brains are functionally abnormal and whether the abnormality is common to all patients with visual hallucinations will require further investigation. These results complement previous studies of consciousness for motion12, 21and support the hypothesis that processing within each specialized visual area makes a direct contribution to conscious vision22, 23.

 Top

METHODS
Patients and controls.
Eight patients with the Charles Bonnet syndrome (seven male, one female) were selected from a questionnaire-based study of visual hallucinations at the Institute of Psychiatry. Selection was based on (i) the frequency of stereotyped hallucinations (> 1 per day), (ii) the absence of psychiatric illness, epilepsy or cognitive impairment (MMSE > 25, ref. 24) and (iii) suitability for an MRI scan. Control patients who had never hallucinated (five males), matched for age, acuity and visual field defect, were recruited from Kings College and St Thomas’ Hospitals. All patients gave informed consent and were given psychiatric, neurological and ophthalmological assessments.


Spontaneous hallucinations.
The room lights were dimmed, and patients were asked to signal the onset and offset of each hallucination, which was recorded on a computer linked to a hand-held keypad in the scanner. One patient logged the events himself; the remaining three raised or lowered a finger while the event was logged by an investigator. Descriptions of the hallucinations were collected after each scan.


Visual stimulation.
A visual stimulus, consisting of five one-minute cycles of 30 s of visual noise (ON) followed by 30 s of a black screen (OFF), was back-projected onto a translucent screen placed over the end of the scanner bore (elongated semi-circular field, 13° vertical times 27° horizontal). The stimulus contained luminance, color, motion and form across a range of spatial and temporal frequencies. Patients were asked to attend the stimulus and to describe their hallucinations after each scan. No attempt was made to correct refractive errors.


Image Acquisition.
Gradient echo, echoplanar images (EPI) were acquired on a 1.5-Tesla GE Signa System (General Electric, Milwaukee) with an Advanced NMR operating console and quadrature birdcage headcoil for radio frequency transmission and reception. In each experiment, 100 T2*-weighted images depicting blood oxygen level-dependent (BOLD) contrast25 (TR = 3 s; TE = 40 ms) were obtained at each of 14, non-contiguous 7-mm slices (0.7 mm interslice spacing), parallel to the plane passing through the anterior and posterior commissures (AC−PC) and covering the whole brain (in-plane resolution 3 times 3 mm). A high-contrast, high-resolution inversion recovery EPI image (TE = 74 ms; TI = 180 ms; TR = 1600 ms; NEX = 8; voxel size = 1.5 times 1.5 times 3.3 mm) was acquired after the experiments.


Image analysis.
In Experiment 1, the time series were motion corrected26, smoothed in x and y (7-mm full width half maximum (FWHM)) and the coefficient of correlation (r) was calculated at each voxel. The process was repeated after shifting the hallucination log with respect to the fMRI time series in steps of one scan (shifts of −9 s, −6 s, −3 s, 0 s, +3 s, +6 s, +9 s) to optimize r for each patient (r max). Probability maps were calculated from the estimated rmax with 100 degrees of freedom and co-registered with the high-resolution structural image. Talairach27 coordinates were derived from transformed r max images (see below). In Experiment 2, the time series were motion corrected26, and the observed and randomized (10 permutations) fundamental power quotient (FPQ) at 0.016 Hz was estimated at each voxel28. FPQ images were transformed into Talairach space using transformation parameters derived from the structural image29. After smoothing in x and y, (20-mm FWHM), generic activation across patients was computed at each voxel by comparing the median observed FPQ with the median randomized FPQ29. Corrections for multiple comparisons were based on the number of independent voxels after smoothing. The phase of activity was calculated from sine and cosine terms in the regression model. The location of generic activation in the original, non-transformed T2*-weighted images was calculated using the transformation parameters derived above. Mean signal within the ventral occipital region of interest over (i) the whole five-minute experiment, (ii) the ON periods and (iii) the OFF periods was corrected for global intersubject differences in maximum signal across the whole slice.

 Top

Received 22 June 1998; Accepted 24 October 1998


REFERENCES

  1. Crick, F. & Koch, C. Consciousness and neuroscience. Cereb. Cortex 8, 97−107 (1998). | Article | PubMed | ISI | ChemPort |
  2. Kölmel, H. W. Complex visual hallucinations in the hemianopic field. J. Neurol. Neurosurg. Psychiatry 48, 29−38 (1985). | PubMed | ISI |
  3. Lepore, F. E. Spontaneous visual phenomena with visual loss. Neurology 40, 444−447 (1990). | PubMed | ISI | ChemPort |
  4. Holroyd, S. et al. Visual hallucinations in patients with macular degeneration. Am. J. Psychiatry 149, 1701−1706 (1992). | PubMed | ISI | ChemPort |
  5. de Morsier, G. Les automatismes visuels. (Hallucinations visuelles rétrochiasmatiques). Schweiz. Med. Woch. 66, 700−703 (1936).
  6. Teunisse, R. J. et al. Visual hallucinations in psychologically normal people: Charles Bonnet’s syndrome. Lancet 347, 794−797 (1996). | Article | PubMed | ISI | ChemPort |
  7. Howard, R. J. et al. Cortical responses to exogenous visual stimulation during visual hallucinations. Lancet 345, 70 (1995). | Article | PubMed | ISI | ChemPort |
  8. Silbersweig, D. A. et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 378, 176−179 (1995). | Article | PubMed | ISI | ChemPort |
  9. Woodruff, P. W. R. et al. Auditory hallucinations and the temporal cortical response to speech in schizophrenia: A functional magnetic resonance imaging study. Am. J. Psychiatry 154, 1676−1682 (1997). | PubMed | ISI | ChemPort |
  10. Boynton, G. M., Engel, S. A., Glover, G. H. & Heeger, D. J. Linear systems analysis of functional magnetic resonance imaging in human V1. J. Neurosci. 16, 4207−4221 (1996). | PubMed | ISI | ChemPort |
  11. Puce, A. et al. Differential sensitivity of human visual cortex to faces, letterstrings, and textures: a functional magnetic resonance imaging study. J. Neurosci. 16, 5205−5215 (1996). | PubMed | ISI | ChemPort |
  12. Zeki, S. & ffytche, D. H. The Riddoch syndrome: insights into the neurobiology of conscious vision. Brain 121, 25−45 (1998). | Article | PubMed | ISI |
  13. Zeki, S. et al. A direct demonstration of functional specialization in human visual cortex. J. Neurosci. 11, 641−649 (1991). | PubMed | ChemPort |
  14. Mckeefry, D. J. & Zeki, S. The position and topography of the human colour centre as revealed by functional magnetic resonance imaging. Brain 120, 2229−2242 (1997). | Article | PubMed |
  15. Penfield, W. & Rasmussen, T. The Cerebral Cortex of Man (Macmillan, New York, 1950).
  16. Kanwisher, N., McDermott, J. & Chun, M. M. The fusiform face area: a module in human extrastriate cortex specialised for face perception. J. Neurosci. 17, 4302−4311 (1997). | PubMed | ISI | ChemPort |
  17. Sergent, J., Ohta, S. & Macdonald, B. Functional neuroanatomy of face and object processing. Brain 115, 15−36 (1992). | PubMed | ISI |
  18. Kanwisher, N., Chun, M. M., McDermott, J. & Ledden, P. J. Functional imaging of human visual recognition. Cog. Brain Res. 5, 55−67 (1996). | Article | ISI | ChemPort |
  19. Howard, R.J. et al. The functional anatomy of imagining and perceiving colour. Neuroreport 9, 1019−1023 (1998). | PubMed | ISI | ChemPort |
  20. Crick, F. & Koch, C. Are we aware of neural activity in primary visual cortex? Nature375, 121−123 (1995). | Article | PubMed | ISI | ChemPort |
  21. ffytche, D. H., Guy, C. N. & Zeki, S. Motion specific responses from a blind hemifield. Brain 119, 1971−1982 (1996). | PubMed | ISI |
  22. Zeki, S. A Vision of the Brain (Blackwell, Oxford, 1993).
  23. ffytche, D. H. & Zeki, S. Brain activity related to the perception of illusory contours. Neuroimage 3, 104−108 (1996). | Article | PubMed | ISI | ChemPort |
  24. Folstein, M. F., Folstein, S. E. & McHugh, P. R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res.12, 189−198 (1975). | Article | ChemPort |
  25. Kwong, K. K. et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc. Natl. Acad. Sci. USA 89, 5675−5679 (1992). | PubMed | ChemPort |
  26. Friston, K. J. et al. Movement-related effects in fMRI time-series. Magn. Reson. Med.35, 346−355 (1996). | PubMed | ISI | ChemPort |
  27. Talairach, J. & Tournoux, P. Co-planar Stereotaxic Atlas of the Human Brain (Thieme, Stuttgart, 1988).
  28. Bullmore, E. et al. Statistical methods of estimation and inference for functional MR image analysis. Magn. Reson. Med. 35, 261−277 (1996). | PubMed | ISI | ChemPort |
  29. Brammer, M.J. et al. Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach. Magn. Reson. Imaging 15, 763−770 (1997). | Article | PubMed | ISI | ChemPort |

Narcolepsy


What is narcolepsy?



Narcolepsy is a chronic neurological disorder caused by the brain’s inability to regulate sleep-wake cycles normally. At various times throughout the day, people with narcolepsy experience fleeting urges to sleep. If the urge becomes overwhelming, individuals will fall asleep for periods lasting from a few seconds to several minutes. In some cases, people may remain asleep for an hour or longer.




What causes narcolepsy?


The cause of narcolepsy is not known. It involves the body’s central nervous system, which includes the brain and spinal cord. Narcolepsy is a genetic disorder. It is caused by a deficiency in the production of a brain chemical that helps neurons talk to each other.


What are the symptoms of narcolepsy?

The following are the most common symptoms of narcolepsy. However, people may experience symptoms differently. Symptoms may include:
  • Excessive daytime sleepiness (EDS). An overwhelming desire to sleep at inappropriate times.
  • Cataplexy. A sudden loss of muscle control ranging from slight weakness to total collapse.
  • Sleep paralysis. Being unable to talk or move for about one minute when falling asleep or waking up.
  • Hypnagogic hallucinations. Vivid and often scary dreams and sounds reported when falling asleep.
Other symptoms include:
  • Automatic behavior. Performing routine tasks without conscious awareness of doing so, and often without memory of it.
  • Disrupted nighttime sleep and waking up often
You may have other difficulties as you cope with this condition including:
  • Feelings of intense fatigue and continual lack of energy
  • Depression
  • Difficulty in concentrating and memorizing
  • Vision (focusing) problems
  • Eating binges
  • Weak limbs
  • Difficulties in handling alcohol
Whatever the age of onset, patients find that the symptoms tend to get worse over the two to three decades after the first symptoms appear. Many older patients find that some daytime symptoms decrease in severity after age 60.

How is narcolepsy diagnosed?

In addition to a complete medical history and physical exam, lab tests to confirm diagnosis and plan treatment may include:
  • Overnight polysomnogram (PSG). A sleep specialist will monitor you during an entire night of sleep. 
  • Multiple sleep latency test (MSLT). This test measures when you fall asleep and how quickly rapid eye movement (REM) sleep occurs.
  • Genetic blood test. To test for a genetic mutation often found in people who tend to have narcolepsy.
Narcolepsy is not definitively diagnosed in most patients until 10 to 15 years after the first symptoms appear.

How is narcolepsy treated?

Specific treatment will be determined by your healthcare provider based on:
  • Your age, overall health, and medical history
  • Severity of the disease
  • Your tolerance for specific medicines, procedures, or therapies
  • Expectations for the course of the disease
  • Your opinion or preference
The goal of treatment of narcolepsy is to help you remain as alert as possible during the day. It’s also important to reduce times when you lose muscle control. Ideally, this can be done using a minimal amount of medicine.
  • Medicines. Central nervous system stimulants are usually prescribed for excessive sleepiness. Antidepressants may help with muscle control.
  • Nap therapy. Two or three short naps during the day may help control sleepiness and maintain alertness.
  • Proper diet
  • Regular exercise
  • Behavioral therapy
There is no cure for narcolepsy. The U.S. Food and Drug Administration has approved a drug called modafinil for the treatment of excessive daytime sleepiness. Two classes of antidepressant drugs — tricyclic antidepressants and selective serotonin reuptake inhibitors — have proved effective in controlling cataplexy in many patients. Drug therapy should be supplemented by behavioral strategies. Many people with narcolepsy take short, regularly scheduled naps at times when they tend to feel sleepiest. Improving the quality of nighttime sleep can combat excessive daytime sleepiness and help relieve persistent feelings of fatigue.
None of the currently available medications enable people with narcolepsy to consistently maintain a fully normal state of alertness. But excessive daytime sleepiness and cataplexy, the most disabling symptoms of the disorder, can be controlled in most patients with drug treatment. Often the treatment regimen is modified as symptoms change.

Key points about narcolepsy

Narcolepsy is a chronic, neurological sleep disorder with no known cause. The main characteristic of narcolepsy is excessive and overwhelming daytime sleepiness, even after adequate nighttime sleep:
  • In addition to a complete medical history and physical exam, there are several lab tests to confirm the diagnosis.
  • The goal of treatment of narcolepsy is to help you remain as alert as possible during the day.
  • Treatment of narcolepsy may include:
    • Medicines
    • Nap therapy
    • Proper diet
    • Regular exercise
    • Behavioral therapy

Next steps

Tips to help you get the most from a visit to your healthcare provider:

  • Know the reason for your visit and what you want to happen.
  • Before your visit, write down questions you want answered.
  • Bring someone with you to help you ask questions and remember what your provider tells you.
  • At the visit, write down the name of a new diagnosis, and any new medicines, treatments, or tests. Also write down any new instructions your provider gives you.
  • Know why a new medicine or treatment is prescribed, and how it will help you. Also know what the side effects are.
  • Ask if your condition can be treated in other ways.
  • Know why a test or procedure is recommended and what the results could mean.
  • Know what to expect if you do not take the medicine or have the test or procedure.
  • If you have a follow-up appointment, write down the date, time, and purpose for that visit.
  • Know how you can contact your provider if you have questions.

Neuroophthalmol. 2010 Sep;30(3):272-5. doi: 10.1097/WNO.0b013e3181e05340.




Hallucinations: A Systematic Review of Points of Similarity and Difference Across Diagnostic Classes

  1. Charles Fernyhough3,4
+Author Affiliations

  1. 1School of Psychiatry and Clinical Neurosciences, The University of Western AustraliaPerth, Western Australia, Australia;

  2. 2Clinical Research Centre, Graylands Hospital, North Metro Health Service–Mental HealthPerth, Western Australia, Australia;

  3. 3Hearing the Voice, c/o School of Education, Durham UniversityDurham, UK;

  4. 4Department of Psychology, Durham UniversityDurham, UK
  1. *To whom correspondence should be addressed; School of Psychiatry and Clinical Neurosciences, The University of Western Australia, 35 Stirling Highway Perth, Western Australia 6009, Australia; tel: +61-8-9341-3685, fax: +61-9384-5128, e-mail: flavie.waters@health.wa.gov.au

Abstract

Hallucinations constitute one of the 5 symptom domains of psychotic disorders in DSM-5, suggesting diagnostic significance for that group of disorders. Although specific featural properties of hallucinations (negative voices, talking in the third person, and location in external space) are no longer highlighted in DSM, there is likely a residual assumption that hallucinations in schizophrenia can be identified based on these candidate features. We investigated whether certain featural properties of hallucinations are specifically indicative of schizophrenia by conducting a systematic review of studies showing direct comparisons of the featural and clinical characteristics of (auditory and visual) hallucinations among 2 or more population groups (one of which included schizophrenia). A total of 43 articles were reviewed, which included hallucinations in 4 major groups (nonclinical groups, drug- and alcohol-related conditions, medical and neurological conditions, and psychiatric disorders). The results showed that no single hallucination feature or characteristic uniquely indicated a diagnosis of schizophrenia, with the sole exception of an age of onset in late adolescence. Among the 21 features of hallucinations in schizophrenia considered here, 95% were shared with other psychiatric disorders, 85% with medical/neurological conditions, 66% with drugs and alcohol conditions, and 52% with the nonclinical groups. Additional differences rendered the nonclinical groups somewhat distinctive from clinical disorders. Overall, when considering hallucinations, it is inadvisable to give weight to the presence of any featural properties alone in making a schizophrenia diagnosis. It is more important to focus instead on the co-occurrence of other symptoms and the value of hallucinations as an indicator of vulnerability.
 2016 Nov 29;12(1):31.

A functional magnetic resonance imaging investigation of visual hallucinations in the human striate cortex.

Author information

  • 1Quaid-e-Azam University, Islamabad, Pakistan.
  • 2University of Gujrat, Gujrat, Pakistan. dr.fayyaz@uog.edu.pk.
  • 3Korea Advanced Institute of Science and Technology, Daejeon, South Korea.
  • 4University of Gujrat, Gujrat, Pakistan.
  • 5Lahore University of Managment Sciences, Lahore, Pakistan. safeeullah@lums.edu.pk.

Abstract

PURPOSE:

Human beings frequently experience fear, phobia, migraine and hallucinations, however, the cerebral mechanisms underpinning these conditions remain poorly understood. Towards this goal, in this work, we aim to correlate the human ocular perceptions with visualhallucinations, and map them to their cerebral origins.

METHODS:

An fMRI study was performed to examine the visual cortical areas including the striate, parastriate and peristriate cortex in the occipital lobe of the human brain. 24 healthy subjects were enrolled and four visual patterns including hallucination circle (HCC), hallucination fan (HCF), retinotopy circle (RTC) and retinotopy cross (RTX) were used towards registering their impact in the aforementioned visual related areas. One-way analysis of variance was used to evaluate the significance of difference between induced activations. Multinomial regression and and K-means were used to cluster activation patterns in visual areas of the brain.

RESULTS:

Significant activations were observed in the visual cortex as a result of stimulus presentation. The responses induced by visual stimuli were resolved to Brodmann areas 17, 18 and 19. Activation data clustered into independent and mutually exclusive clusters with HCC registering higher activations as compared to HCF, RTC and RTX.

CONCLUSIONS:

We conclude that small circular objects, in rotation, tend to leave greater hallucinating impressions in the visual region. The similarity between observed activation patterns and those reported in conditions such as epilepsy and visual hallucinations can help elucidate the cortical mechanisms underlying these conditions. Trial Registration 1121_GWJUNG.



Consciousness
Dualism vs. Monism
Dualism
Humans consist of thought and matter.
Matter is nonmaterial. arises from, but is independent of the brain. This gives
humans free will.
Monism
Thought and matter are aspects of the
same substance.  Thought stops existing
when the body dies
Description: https://media.licdn.com/mpr/mpr/shrinknp_800_800/AAEAAQAAAAAAAANCAAAAJGM4ZDMyYWVkLWY1YzEtNDVmYy1iZjJhLTliZDE1MzFkN2I5ZA.jpg
Mere-Exposure
Effect
We prefer stimuli that we have seen before over novel
stimuli, even if we don’t consciously remember seeing it
Priming
Research participants respond more quickly/accurately to
questions they’ve seen before, even if they don’t remember it
Description: http://www.jolyon.co.uk/wp-content/uploads/2015/04/Image-65.jpg
Blind Sight
One level of consciousness isn’t getting visual
information. Behavior demonstrates that at another level there is awareness.
Consciousness is our level of awareness about us and our
environment
Types
of Consciousness
The consciousness mind is your awareness
of the present moment. You are aware of something on the outside as well as
some specific mental functions happening on the inside. For example, you are aware
of your environment, your breathing, or the chair that you are sitting on.
Consciousness is also a factor in our own minds that set
us off from the other species on the planet. 
It is an awareness of ourselves, but it is also an awareness of our own
mortality.  We realize that this state of
being can stop at any time.  Since we are
aware of our own impermanence, we have constructed many theories and ideas that
focus on the continuation of our consciousness. 
This can be either a belief in ghosts or religion but all aid us in a
search for immortality.
The subconscious mind or
the preconscious mind
consists of accessible information. You can become aware
of this information once your direct your attention to it.
Think of this as memory recall. You walk down the street
to your house without consciously needing to be alert to your surroundings. You
can talk on the cell phone and still arrive home safely. You can easily bring
to consciousness the subconscious information about the path to your home. You
can also easily remember phone numbers that you frequently use.
It is possible that some of what might be perceived to be
unconscious becomes subconscious, and then conscious (e.g. a long-forgotten
childhood memory suddenly emerges after decades). We can assume that some
unconscious memories need a strong, specific trigger to bring them to
consciousness; whereas, a subconscious memory can be brought to consciousness
more easily.
The unconscious mind consists of
primitive, instinctual wishes as well as information that we cannot access.
Although our behaviors might indicate the unconscious forces that drive them,
we don’t have easy access to the information stored in the unconscious mind.
During our childhood, we acquired countless memories and experiences that
formed who we are today. However, we cannot recall most of those memories. They
are unconscious forces (beliefs, patterns, subjective maps of reality) that
drive our behaviors.
The existence of the Subconscious and the Unconscious
mind
has always raised interesting questions.  Why are they hidden?  From an evolutionary perspective, the Unconscious
is understandable.  It is a well of
ancient primeval drives that once kept us alive but now are socially
unacceptable.  But the Subconscious is
more problematic.  Why isn’t this
information readily apparent?  Why hide
it?
Description: http://www.dialogueworks.com/ckfinder/userfiles/images/Conscious%20Subconscious%20Unconscious.jpg
Description: 54749_05_04
Sleep
Sleep Cycle
Circadian
rhythm
Most people notice that they naturally experience
different levels of sleepiness and alertness throughout the day, but what
causes these patterns?
Sleep is regulated by two body systems: sleep/wake
homeostasis
and the circadian biological clock .
When we have been awake for a long period of time,
sleep/wake homeostasis tells us that a need for sleep is accumulating and that
it is time to sleep. It also helps us maintain enough sleep throughout the
night to make up for the hours of being awake. Sleep/wake homeostasis
creates a drive that balances sleep and wakefulness.
Our internal circadian biological clocks,
on the other hand, regulate the timing of periods of sleepiness and wakefulness
throughout the day.
The circadian rhythm dips and rises at different times of
the day, so adults’ strongest sleep drive generally occurs between 2:00-4:00 am
and in the afternoon between 1:00-3:00 pm. The circadian rhythm also causes us
to feel more alert at certain points of the day.
Changes to this circadian rhythm occur during adolescence,
when most teens experience a sleep phase delay. This shift in
teens’ circadian rhythm causes them to naturally feel alert later at night,
making it difficult for them to fall asleep before 11:00 pm.
Since most teens have early school start times along with
other commitments, this sleep phase delay can make it
difficult to get the sleep teens need — an average of 9 1/4 hours, but at
least 8 hours. This sleep deprivation can influence the circadian rhythm.
For teens,  the
strongest circadian “dips” tend to occur between 3:00-7:00 am and 2:00-5:00 pm,
but the morning dip (3:00-7:00 am) can be even longer if teens haven’t had
enough sleep, and can even last until 9:00 or 10:00 am.
The circadian biological clock is controlled by a part of
the brain called the Suprachiasmatic Nucleus (SCN), a
group of cells in the hypothalamus that respond to light
and dark signals. From the optic nerve of the eye, light travels to the SCN,
signaling the internal clock that it is time to be awake. The SCN signals to
other parts of the brain that control hormones, body temperature and other functions
that play a role in making us feel sleepy or awake.
In the mornings, with exposure to light, the SCN sends
signals to raise body temperature and produce hormones
like cortisol.
The SCN also responds to light by delaying the release of other
hormones like melatonin, which is associated with sleep onset and is produced
when the eyes signal to the SCN that it is dark.
Circadian disruptions such as jet lag put us in conflict
with our natural sleep patterns, since the shift in time and light cues on the brain
forces the body to alter its normal pattern to adjust.
Sleep Onset – is the transition from wakefulness
into sleep. Sleep onset usually transmits into non-rapid eye movement sleep
(NREM sleep) but under certain circumstances (e.g. narcolepsy, infancy) it is
possible to transmit from wakefulness directly into rapid eye movement sleep
(REM sleep).
Sleep Onset
Imagery
– images and
experiences during the moments following the transition from wake to sleep
Sleep paralysis – waking and not being able to move
for a short period of time, usually occurs out of REM (dream) sleep
Description: http://www.mind-your-reality.com/images/brainwaves_chart.jpg
Stage 1 is sleep onset. 
The brain produces Theta
waves and they get slower and higher in amplitude as we approach Stage 2. Sleep spindles are brief bursts of fast
brainwave activity occur in this period.
Stage 2 is where we spend the majority of the night while
sleeping. Typically, more time is spent in stage 2 sleep than in light sleep,
deep sleep or dream sleep.
Sleep spindles are brief bursts of fast brainwave activity occur in this
period.
The greatest spindle activity occurs at
the beginning and the end of the non-REM portion of the sleep cycle
Stages 3 and 4 – slow-wave sleep – the slower the
waves, the deeper the sleep.  Delta waves
are produced in these periods. This is the time of REM sleep.
REM sleep occurs in cycles of about 90-120
minutes throughout the night, and it accounts for up to 20-25% of total sleep
time, although the proportion decreases with age (a newborn baby may spend 80%
of total sleep time in the REM stage).
As the name
suggests, it is associated with rapid (and apparently random) side-to-side
movements of the closed eyes. This eye motion is not constant but intermittent.
It is still not
known exactly what purpose this movement serves, but it is believed that the
eye movements may relate to the internal visual images of the dreams
that occur during REM sleep, especially as they are associated with brain wave
spikes in the regions of the brain involved with vision.
Brain activity
during REM sleep is largely characterized by low-amplitude
mixed-frequency brain waves, quite similar to those experienced during the
waking state – theta waves, alpha waves and even the high frequency beta waves
more typical of high-level active concentration and thinking. Because of the
similarities with the waking state, REM sleep has earned the moniker “paradoxical
sleep
”.
The brain’s
oxygen consumption, reflecting its energy consumption, is also very high during
this period, in fact often higher than when awake and working on a complex
problem. Breathing becomes more rapid and irregular during REM sleep
than during non-REM sleep, and the heart rate and blood pressure also increase
to near waking levels
. Core temperature is not well regulated
during this time and tends towards the ambient temperature, in much the same
way as reptiles and other cold-blooded animals.
Sexual arousal is also
common during REM sleep regardless of whether or not any dreams in progress are
of an erotic nature.
Although the muscles
become
more relaxed during non-REM sleep, they become completely paralyzed and
unresponsive during REM sleep
. This virtual absence of muscle tone and
skeletal muscle activity is known as atonia, and it occurs because the
brain impulses that control muscle movement are completely suppressed (other
than those controlling the eye movements and one or two other essential
functions, like the heart, diaphragm, etc, that allow us to breathe and remain
alive).
Description: http://www.end-your-sleep-deprivation.com/images/how-sleep-paralysis-occurs.jpg
The majority of
dreams – certainly the most memorable and vivid dreams – occur during REM
sleep, and it is thought that the muscular atonia that accompanies it may
be a built-in measure to protect us from self-damage which could occur while
physically acting out these vivid REM dreams.
This hypothesis is borne
out by Michel Jouvet’s early experiments on cats in which the muscle
inhibition nerves were severed, leading these cats to physically stalk
invisible prey and run and jump around wildly during the dreams of REM sleep.
Description: https://sommeil.univ-lyon1.fr/articles/jouvet/scientific_american/images/fig2.gif
REM rebound will occur if we are deprived of REM
sleep, we will spend more time in REM the following night.
Description: http://smashingtops.com/wp-content/uploads/2011/08/Sleepwalking.jpg
Sleep Disorders
A sleep
disorder – technically known as a somnipathy or dyssomnia – is any
medical disorder which negatively affects a person’s healthy sleep patterns.
Usually this involves less than adequate sleep to the extent that this may
interfere with the person’s normal physical, mental and emotional functioning,
but excessive
sleep (such as in hypersomnia and narcolepsy) can also be a problem
. At
least seventy, or by some counts over a hundred, different disorders that can
affect sleep have been identified, the most common and well-known being insomnia,
sleep apnea and restless legs syndrome.
Insomnia
Insomnia is a
very common complaint – indeed, the most commonly diagnosed sleep disorder –
affecting some 30% to 50% of the general population according to some
estimates, with about 10% of the population suffering from long-standing or
chronic insomnia. It can occur at any age, but is most common in the elderly.
It is also generally more common among women than men.
The number one
cause of episodic or transient insomnia is stress and anxiety, whether
from school- or job-related pressures, family or marriage problems, serious
illness or death in the family, etc.
If short-term
insomnia is not managed properly, it can morph into a long-term problem,
persisting long after the original stress has passed. Most insomniacs tend to
be anxiety-prone by nature.
At the extreme end of the scale, there
is a very rare genetic sleep disorder called fatal familial insomnia (FFI),
which appears in a handful of families in late adulthood, and which is in fact
quite as fatal as the name suggests. In FFI, malformed proteins called prions
attack the thalamus, an organ in the brain that plays a major role in
regulating sleep. The sufferer gradually completely loses the ability to sleep,
first the ability to nap and then the ability to sleep at night. Hallucinations
soon follow, then rapid weight loss and dementia, and finally complete
unresponsiveness. Within a year of striking, the disease causes death
Description: Image result for familial fatal insomnia
Narcolepsy
Narcolepsy is a
neurological disorder that affects the control of sleep and wakefulness. People
with narcolepsy experience excessive daytime sleepiness and intermittent,
uncontrollable episodes of falling asleep during the daytime
. These
sudden sleep attacks may occur during any type of activity at any time of the
day.
For people
suffering from narcolepsy, REM sleep occurs almost immediately in the sleep
cycle, as well as periodically during the waking hours. Narcolepsy usually
begins between the ages of 15 and 25, but it can become apparent at any age.
·     
What Causes Narcolepsy?
The cause of
narcolepsy is not known; however, scientists have made progress toward
identifying genes strongly associated with the disorder. Some experts think
narcolepsy may be due to a deficiency in the production of a chemical called
hypocretin by the brain What Are the Symptoms of Narcolepsy?
•Excessive
daytime sleepiness (EDS)
In general, EDS
interferes with normal activities on a daily basis, whether or not a person
with narcolepsy has sufficient sleep at night. People with EDS report mental
cloudiness, a lack of energy and concentration, memory lapses, a depressed
mood, and/or extreme exhaustion.
•Cataplexy
 This symptom consists of a sudden loss of
muscle tone that leads to feelings of weakness and a loss of voluntary muscle
control. It can cause symptoms ranging from slurred speech to total body
collapse, depending on the muscles involved, and is often triggered by intense
emotions such as surprise, laughter, or anger.
•Hallucinations
 Usually, these delusional experiences are
vivid and frequently frightening. The content is primarily visual, but any of
the other senses can be involved. These are called hypnagogic hallucinations when
accompanying sleep onset and hypnopompic hallucinations when they occur during
awakening.
Sleep apnea
as common as
insomnia – causes you to stop breathing for short periods of time at night -wake
up slightly and gasp for air – won’t remember waking  – affects attention, memory, energy – prevents
deep sleep – high risk group: overweight men (Fisher)
Night terrors
and somnambulism (sleep walking
)
more common in
children – early in the night; stage 4 – not remembered in the morning
Description: http://www.powerofdreams.net/images/DreamingBrain1.jpg
Description: http://www.dreaminterpretation-dictionary.com/images/DreamSymbolism250.jpg
Dreams
·     
We May Dream Because of Random Impulses
In 1977, Hobson
& McCarley put forward some dream research that said that dreaming is the
result of random impulses coming from the brain stem.
Using an EEG
machine, the researchers were able to track the regular REM states of people
during sleep. They used this data to form a predictable mathematical model and
conclude that dreaming is a freak physiological (bodily) occurrence – rather
than a psychological function.
According to
them, the fact that we see images and hear sounds in our dreams is simply the
brain’s way of understanding noisy electrical signals. They said that dreams
are random and meaningless.
·     
We May Dream to Organize The Brain
We may dream to
de-clutter our brains. Every day we are bombarded with new information, both
consciously (eg learning) and unconsciously (eg advertising).
This modern
dream theory suggests dreaming is a way to file away key information and
discard meaningless data. It helps keep our brains organized and optimizes our
learning. This theory hasn’t been proven by dream research. If it were 100%
correct, our entire day would be replayed to us during our REM sleep!
Critics of this
theory also point out that our brains are not the same as computers, and to
draw a comparison to filing, processing and storage space is likely to be
inaccurate. They also point out that although some of our dreams relate back to
the waking day (Freud called this “day residue”), the majority of our
dreams are not about real world events.
Description: http://images.sciencedaily.com/2014/04/140413135953-large.jpg
·     
We May Dream to Help Solve Problems
A number of
researchers think that dreams are for mental and emotional problem solving.
Fiss claimed
that our dreams help us to register very subtle hints that go unnoticed during
the day. This explains why “sleeping on it” can provide a solution to
a problem.
Unfortunately,
there are also arguments against this theory of dreaming. For a start, most
people only remember a very small number of their dreams.
·     
We May Dream to Cope With Trauma
Dreams may be a
way of coping with trauma. Based on the intensity of our emotions, we will
generate dreams to cope with certain situations.
For instance,
if you escape from a house fire and the experience shakes you up, chances are
you will dream about it that night. The more traumatic the event, the more
emotions are felt, and the more important it is to get over it. Dreaming about
the fire will help you come to terms with what happened and prepare you for it
ever happening again.
Of course, this
doesn’t explain why we dream of fantastic or mundane things – only that
nightmares can be a kind of rehearsal for trauma.
Description: http://www.stolaf.edu/depts/ciswp/khughes/pictures/freudianslip.png
Freudian
psychoanalysis
Freudian
analysis emphasizes dream interpretation as a way to uncover information in the
unconscious mind.  Dreams are seen as
wish fulfillment.  In dreams we act out
our unconscious desires
Analysis relies
on two main factors:
Manifest content which is the literal storyline of the
dream.  This is to make the patient aware
of their own role in constructing the dream.
Description: http://wordpandit.com/wp-content/uploads/2012/09/Latent.jpg
Latent content which is the unconscious meaning of
the symbols in the dream. 
Freud argued that dreams themselves couldn’t be fully
trusted because the ego protects us from information in the unconscious
mind.  He called it “protected sleep”
Description: http://dreamstudies.org/wp-content/uploads/2010/01/Picture-3-99x190.png
Activation-synthesis
theory
John Allan
Hobson emphasizes the role of neurochemicals in the brain and random electrical
impulses originating in the brainstem.  He
once stated that dreams are the random firing of neurons, he has since updated
this view to say that dreams are the brain’s cobbled attempt at making sense of
them.
Hobson believes
Freud had it wrong. He may even have impeded our scientific understanding of
the nature of dreams by propagating such ominous theories. Hobson is all for a
psychological meaning to dreams, but just that it needn’t be locked away under
layers of secretive unconscious meaning. Instead, Hobson takes a Jungian
approach: dreams reveal far more than they hide – and can actually be highly transparent.
However, it’s difficult to link this conclusion to Hobson’s biological
explanation for dreaming.
But the theory
does make sense. Next time you dream of being chased, isn’t it likely that you
are – metaphorically – running away from something in real life that’s causing
you anxiety? And if you dream of being pregnant – for a woman at least – is
this a natural expression of your desire to have babies?
Dreams are the
brain’s interpretation of what is happening physiologically during REM sleep
a.     Information-processing theory. the
function of REM is to integrate information processed during the day into our
memory
b.     Evidence to support: stress increases
the number and the intensity of our dreams, dream content often relates to
daily concerns, babies REM more
Other Theories
of Dreams
Many other
theories have been suggested to account for the occurrence and meaning of
dreams. The following are just of few of the proposed ideas:
External
Stimuli
theory suggests that dreams are the result of our brains trying
to interpret external stimuli during sleep. For example, the sound of the radio
may be incorporated into the content of a dream
Housekeeping
theory uses a computer metaphor to account for dreams. According to this
theory, dreams serve to ‘clean up’ clutter from the mind, much like clean-up
operations in a computer, refreshing the mind to prepare for the next day.
Psychotherapy
model proposes that dreams function as a form of psychotherapy. In this theory,
the dreamer is able to make connections between different thoughts and emotions
in a safe environment
Description: http://www.possibilities.nu/providence_hypnosis_ri.jpg
Hypnosis
Posthypnotic
Amnesia is literally the process of forgetting events that occurred while you
were under hypnosis
Posthypnotic Suggestion
is a suggestion that a hypnotized person behave in a certain way after hypnosis
ends
Why does
hypnosis work?
* Role Theory
During hypnosis, people act out the role of a hypnotized
person because they are expected to
Hypnosis is a social phenomenon
Hypnotic suggestibility is the ability to be hypnotized. 
It is higher in people who:
1.    
Are prone to involuntary movement
2.    
Have rich fantasy lives
3.    
Can focus intensely on a single task for a long time
which allows for loss of time.
4.    
Are able to suspend their critical judgment and accept
incongruous answers to problems.
5.    
Follow directions well to the point of compulsive
compliance
Description: http://news.stanford.edu/news/2001/october31/gifs/hilgardmug_160.jpg
* Dissociation
Theory
Main thinker here is Ernest Hilgard. 
Hypnosis causes a voluntary split in consciousness.  On one level the subject responds to the
suggestions of the hypnotist on another level they retain an awareness of
reality
Ice water bath experiment.  In this, subjects felt pain but reported none.  The premise is that this demonstrates the
presence of a hidden observer.  This
could be a level of our consciousness that monitors what is happening while
another level obeys the hypnotist
Description: i-93c94ef329ecfb19c96ef8bcdc79776d-Resize of parapsychology_cartoon_lab.gif
Parapsychology
Parapsychology is a pseudoscience concerned with
paranormal and psychic phenomena which includes telepathy, precognition,
clairvoyance, psychokinesis, near-death experiences, reincarnation,
apparitional experiences, and other paranormal claims
Parapsychology research is largely conducted by private
institutions in several different countries and funded through private
donations, and the subject rarely appears in mainstream science journals.
A number of universities have academic parapsychology
programs.
Koestler Parapsychology Unit at the University
of Edinburgh
Parapsychology Research Group at Liverpool
Hope University
Center for the Study of Anomalous
Psychological Processes at the University of Northampton
Anomalistic
Research Unit at Goldsmiths University of London.
Division of Perceptual Studies  University of Virginia
Veritas Laboratory    University of Arizona
SOPHIA Project at the
University
of Arizona
Description: https://parapsychologyonline.files.wordpress.com/2014/11/123rf-17142114_l-parapsychology-mooc-logo-by-radiantskies.jpg
Scope
Parapsychologists study paranormal phenomena, including
but not limited to:
Telepathy: Transfer of
information on thoughts or feelings between individuals by means other than the
five classical senses.
Precognition: Perception of
information about future places or events before they occur.
Clairvoyance: Obtaining
information about places or events at remote locations, by means unknown to
current science.
Psychokinesis: The ability
of the mind to influence matter, time, space, or energy by means unknown to
current science.
Near-death
experiences
: An experience reported by a person who nearly died, or
who experienced clinical death and then revived.
Apparitional
experiences
: Phenomena often attributed to ghosts and encountered in
places a deceased individual is thought to have frequented, or in association
with the person’s former belongings.
Anomalistic psychology
In anomalistic psychology, paranormal phenomena have
natural explanations resulting from psychological and physical factors
The difference between anomalistic psychology and
parapsychology is in terms of the aims of what each discipline is about.
Parapsychologists typically are actually searching for
evidence to prove the reality of paranormal forces, to prove they really do
exist. So the starting assumption is that paranormal things do happen.
Anomalistic psychologists tend to start from the position
that paranormal forces probably don’t exist and that therefore we should be
looking for other kinds of explanations, in particular the psychological
explanations for those experiences that people typically label as paranormal.
Parapsychology has been said to be in decline,
anomalistic psychology has been reported to be on the rise. It is now offered
as an option on many psychology degree programs
Description: http://bendleappsych.wikispaces.com/file/view/drugclassification_chart.gif/280188846/800x653/drugclassification_chart.gif
Drugs
Psychoactive
Drugs
Chemicals that change the chemistry of the brain and induce
an altered state of consciousness. Examples include tobacco, alcohol, cannabis,
amphetamines, ecstasy, cocaine, and heroin.
Psychoactive drugs are divided into different groups
according to their pharmacological effects. Commonly used psychoactive drugs
and groups:
Anxiolytics – example: Xanax, Librium, Klonopin, Valium, Ativan, Halcion
Euphoriants – example: MDMA (Ecstasy), MDA, 6-APB, Indopan
Stimulants (“uppers”). This category comprises substances
that wake one up, stimulate the mind, and may even cause euphoria, but do not
affect perception – Examples: amphetamine, caffeine, cocaine, nicotine
Depressants (“downers”), including sedatives, hypnotics,
and narcotics. This category includes all of the calmative, sleep-inducing,
anxiety-reducing, anesthetizing substances, which sometimes induce perceptual
changes, such as dream images, and also often evoke feelings of euphoria.
Examples: ethanol (alcoholic beverages), opioids,
barbiturates, benzodiazepines.
Hallucinogens, including psychedelics, dissociatives and
deliriants
. This category encompasses all those substances that produce distinct
alterations in perception, sensation of space and time, and emotional states
Examples: psilocybin, LSD, Salvia Divinorum, PCP and
nitrous oxide.
Description: http://www.newyorker.com/wp-content/uploads/2014/09/gary-marcus-brain-scan-320-240.jpg
How they work
Psychoactive drugs operate by temporarily affecting a
person’s neurochemistry, which in turn causes changes in a person’s mood,
cognition, perception and behavior.
Drugs that increase activity in particular
neurotransmitter systems are called agonists. They act by increasing the
synthesis of one or more neurotransmitters, by reducing its reuptake from the
synapses, or by mimicking the action by binding directly to the postsynaptic
receptor.
Drugs that reduce neurotransmitter activity are called
antagonists, and operate by interfering with synthesis or blocking postsynaptic
receptors so that neurotransmitters cannot bind to them.
Exposure to a psychoactive substance can cause changes in
the structure and functioning of neurons, as the nervous system tries to
re-establish the homeostasis disrupted by the presence of the drug
Exposure to antagonists for a particular neurotransmitter
can increase the number of receptors for that neurotransmitter or the receptors
themselves may become more responsive to neurotransmitters; this is called
sensitization.
Overstimulation of receptors for a particular
neurotransmitter may cause a decrease in both number and sensitivity of these
receptors, a process called desensitization or tolerance.
These processes are thought to play a role in drug
dependence and addiction. Physical dependence on antidepressants or anxiolytics
may result in worse depression or anxiety, respectively, as withdrawal
symptoms. Unfortunately, because clinical depression (also called major
depressive disorder) is often referred to simply as depression, antidepressants
are often requested by and prescribed for patients who are depressed, but not
clinically depressed.


Reversible blindness: simple partial seizures presenting as ictal and postictal hemianopsia.

Author information

  • 1Department of Neurology, Georgetown University Hospital, Washington, District of Columbia 20007, USA. pt.ghosh@yahoo.com

Abstract

A 34-year-old woman developed a sustained right homonymous hemianopia and episodic visual hallucinations 8 days after liver transplant surgery. Neuro-ophthalmologic examination and perimetry confirmed a right homonymous hemianopia with macular sparing. The patient’s vital signs and laboratory values, including a comprehensive metabolic panel and drug levels, were unremarkable. Brain MRI with and without contrast was also unremarkable. A video electroencephalogram revealed frequent, recurrent, left occipitoparietotemporal simple partial seizures associated with episodes of eyelid fluttering, right gaze preference, visual hallucinations, and a dense right hemianopia that persisted interictally. After treatment of the seizures with levetiracetam, perimetry showed resolution of the right homonymous hemianopia. This case demonstrates many classic features of occipital and parietal seizures. It also suggests that, unlike previously reported cases of enduring visual field deficits after cessation of seizures, early diagnosis and management of visual seizures may prevent permanent visual field deficits.

Improvement in Psychotic Symptoms After a Gluten-Free Diet in a Boy With Complex Autoimmune Illness

William W. Eaton, Ph.D., Lian-Yu Chen, M.D., F. Curtis Dohan, Jr., M.D., Deanna L. Kelly, Pharm. D., and Nicola Cascella, M.D.

DISCUSSION

Schizophrenia is currently thought to be heterogeneous in its etiology as well as its symptomatology, with a range of subtypes (). The illness was originally assumed to have a degenerative course, but there have always been cases of recovery in persons originally diagnosed as having schizophrenia (), a variation that may be associated with etiologic subtypes. There is a wide range of possible etiologic subtypes, including syndromes relevant to immune dysfunction that may be associated with infections (), with autoimmune diseases (), or with the combination of these two mechanisms (). A candidate autoimmune condition is celiac disease (), for which there is a substantial clinical, epidemiologic, and experimental scientific literature () extending back to the work of Graff and Handford in 1961 () and the work of Dohan in 1970 (). There have been case reports of dramatic recovery from schizophrenia associated with implementation of a gluten-free diet (). The results of clinical trials involving gluten-free diets are mixed, however, perhaps because of the etiologic heterogeneity of schizophrenia (). It is possible that the immunological effects of gluten in schizophrenia are not limited to celiac disease, but also include various forms of nonceliac immune-mediated gluten sensitivity (). It has been shown repeatedly that persons with schizophrenia have higher immune-mediated gluten sensitivity that is not connected to celiac disease (), as compared with the general population.
This case presents a variety of immunological abnormalities in the patient and his family that may have a relationship to his psychosis. The father’s hypothyroidism may be particularly relevant, since hypothyroidism is associated with a higher risk of psychosis in the offspring as well as in the proband (). The patient’s recurrent otitis media is also noteworthy, since otitis media during childhood has been associated with a higher risk of schizophrenia (). The patient’s early eosinophilic gastritis and his IgE antibodies to gluten suggest the possibility of a predisposition to an IgE-mediated activation of the immune system. It is not clear from the literature whether high ANA levels are uniformly associated with a diagnosis of schizophrenia, as there are several reports of no differences between cases and controls ().
We believe that the loss of hearing in this patient is attributable to a different immune mechanism than the allergic reaction to gluten that is potentially related to his psychosis. Indeed, the patient’s maternal uncle had hearing loss and was positive for ANAs, but unlike the patient, he did not have psychosis. In favor of this hypothesis is the fact that the patient’s schizophrenia symptoms remitted after he started a gluten-free diet, while his autoimmune inner ear disease, which may already have been triggered at the time of the initial ANAs while the patient was eating gluten, continued to progress. The presence of only IgE antibodies to gluten in the patient raises the possibility that his psychotic symptoms could be associated not only with the presence of antigliadin (AGA) and/or tissue transglutaminase antibodies (as currently reported in the literature) but also with IgE antibodies.
The remission of psychotic symptoms in this patient has been associated with maintenance of the gluten-free diet, but it is also possible that the minocycline he was taking for acne contributed to his recovery, since this antibiotic has been associated with improvement of schizophrenia symptoms in several studies (). However, both risperidone and minocycline have since been discontinued. This leaves the distinct possibility that the withdrawal of gluten from the diet was the crucial factor in the patient’s recovery, which fits with our previously reported finding () that improvements in symptoms begin as soon as 2 weeks after a gluten-free diet is started in persons with schizophrenia who have antigliadin antibodies. However, the basis for the response of the patient’s schizophrenia symptoms to a gluten-free diet is not completely clear. An immune-mediated reaction to gluten could trigger a neuroinflammatory process, with associated impairment of the permeability of the blood-brain barrier. We recently reported an increased prevalence of antibodies for transglutaminase 6, specifically expressed in the brain, in schizophrenia patients who were positive for AGA antibodies (). We described the findings as a marker of neuroinflammation in gluten-sensitive schizophrenia patients. Similarly, the allergic reaction to gluten in the patient described here could result in a neuroinflammatory process.
Regardless of the exact mechanism involved, the marked improvement in this patient’s schizophrenia symptoms after implementation of a gluten-free diet and the multiple similar cases in the literature () underscore the need for further research on the role of diet in schizophrenia, as well as the potential importance of a personal or family history of autoimmune diseases in identifying patients who may be responsive to dietary treatment.

Acknowledgments

Supported by NIMH grant 1R34MH100776-01.
Dr. Kelly has served as an adviser to XOMA and Lundbeck.

Footnotes

The other authors report no financial relationships with commercial interests.

REFERENCES

1. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry. 2006;11:815–836. [PubMed]
2. Ram R, Bromet EJ, Eaton WW, et al. The natural course of schizophrenia: a review of first-admission studies. Schizophr Bull. 1992;18:185–207. [PubMed]
3. Arias I, Sorlozano A, Villegas E, et al. Infectious agents associated with schizophrenia: a meta-analysis. Schizophr Res. 2012;136:128–136. [PubMed]
4. Eaton WW, Byrne M, Ewald H, et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006;163:521–528. [PubMed]
5. Benros ME, Mortensen PB, Eaton WW. Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci. 2012;1262:56–66. [PubMed]
6. Eaton W, Mortensen PB, Agerbo E, et al. Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers. BMJ. 2004;328:438–439. [PMC free article][PubMed]
7. Kalaydjian AE, Eaton W, Cascella N, et al. The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand. 2006;113:82–90. [PubMed]
8. Graff H, Handford A. Celiac syndrome in the case histories of five schizophrenics. Psychiatr Q. 1961;35:306–313. [PubMed]
9. Dohan FC. Coeliac disease and schizophrenia. Lancet. 1970;1:897–898. [PubMed]
10. De Santis A, Addolorato G, Romito A, et al. Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. J Intern Med. 1997;242:421–423. [PubMed]
11. Jansson N, Kristjánsson E, Nilsson L. Schizophrenic psychosis disappearing after patient is given gluten-free diet. Lakartidningen. 1984;81:448–449. [PubMed]
12. Kraft BD, Westman EC. Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature. Nutr Metab (Lond) 2009;6:10. [PMC free article] [PubMed]
13. King DS. Statistical power of the controlled research on wheat gluten and schizophrenia. Biol Psychiatry. 1985;20:785–787. [PubMed]
14. Hadjivassiliou M, Grünewald RA, Davies-Jones GA. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry. 2002;72:560–563. [PMC free article] [PubMed]
15. Hadjivassiliou M, Sanders DSG, Grünewald RA, et al. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010;9:318–330. [PubMed]
16. Lachance LR, McKenzie K. Biomarkers of gluten sensitivity in patients with non-affective psychosis: a meta-analysis. Schizophr Res. 2014;152:521–527. [PubMed]
17. Eaton WW, Pedersen MG, Nielsen PR, et al. Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord. 2010;12:638–646. [PMC free article] [PubMed]
18. Heinrich TW, Grahm G. Hypothyroidism presenting as psychosis: myxedema madness revisited. Prim Care Companion J Clin Psychiatry. 2003;5:260–266. [PMC free article] [PubMed]
19. Kupka RW, Nolen WA, Post RM, et al. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry. 2002;51:305–311. [PubMed]
20. Mason P, Rimmer M, Richman A, et al. Middle-ear disease and schizophrenia: case-control study. Br J Psychiatry. 2008;193:192–196. [PubMed]
21. Sidhom O, Laadhar L, Zitouni M, et al. Spectrum of autoantibodies in Tunisian psychiatric inpatients. Immunol Invest. 2012;41:538–549. [PubMed]
22. Keller WR, Kum LM, Wehring HJ, et al. A review of anti-inflammatory agents for symptoms of schizophrenia. J Psychopharmacol. 2013;27:337–342. [PMC free article] [PubMed]
23. Torrey EF, Davis JM. Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas. Clin Schizophr Relat Psychoses. 2012;5:208–216. [PubMed]
24. Jackson J, Eaton W, Cascella N, et al. A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies. Schizophr Res. 2012;140:262–263. [PMC free article][PubMed]
25. Cascella NG, Santora D, Gregory P, et al. Increased prevalence of transglutaminase 6 antibodies in sera from schizophrenia patients. Schizophr Bull. 2013;39:867–871. [PMC free article] [PubMed]


 2001 Feb;41(2):224-7.

Visual hallucination and tremor induced by sertraline and oxycodone in a bone marrow transplant patient.

Author information

  • 1Department of Pharmacology and Medicine, Division of Clinical Pharmacology, Georgetown University Medical Center, Washington, DC 20007, USA.

Abstract

The authors report a case of probable serotonin syndrome caused by the coadministration of sertraline and oxycodone. A 34 year-old male patient experienced visual hallucinations and severe tremor after dramatically increasing his dosage of oxycodone while on stable amounts of sertraline and cyclosporin. Discontinuation of cyclosporin did not result in resolution of his symptoms. Consideration of a possible sertraline-oxycodone interaction led to withholding sertraline, which resulted in symptom resolution. Serotonin syndrome has been noted with sertraline in combination with other drugs, but this is the first report in combination with a narcotic analgesic. Possible pharmacological mechanisms are discussed. In complicated patients that are taking multiple medications, physicians should be aware of this possible interaction to avoid delay in the diagnosis of serotonin syndrome.




References:


ARTICLE
Nature Neuroscience  1, 738 – 742 (1998)
doi:10.1038/3738

The anatomy of conscious vision: an fMRI study of visual hallucinations

D. H. ffytche, R. J. Howard, M. J. Brammer, A. David, P. Woodruff & S. Williams

Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK


Correspondence should be addressed to D. H. ffytche d.ffytche@iop.bpmf.ac.uk

Despite recent advances in functional neuroimaging, the apparently simple question of how and where we see—the neurobiology of visual consciousness—continues to challenge neuroscientists. Without a method to differentiate neural processing specific to consciousness from unconscious afferent sensory signals, the issue has been difficult to resolve experimentally. Here we use functional magnetic resonance imaging (fMRI) to study patients with the Charles Bonnet syndrome, for whom visual perception and sensory input have become dissociated. We found that hallucinations of color, faces, textures and objects correlate with cerebral activity in ventral extrastriate visual cortex, that the content of the hallucinations reflects the functional specializations of the region and that patients who hallucinate have increased ventral extrastriate activity, which persists between hallucinations.

Few imaging studies have investigated the conscious ‘pictures’ of the external environment that we associate with seeing (visual percepts). The problem that confronts the neuroscientist is recognizing the neural correlate of ‘seeing’ and differentiating it from afferent sensory activity, which is assumed to remain unconscious1. One solution is to study a visual system in which percepts have become dissociated from sensory input. Such dissociation can follow a sudden deterioration in visual abilities in patients who in other respects are neuropsychiatrically normal2, 3, 4. This syndrome is termed the Charles Bonnet syndrome (named after the Swiss philospher who first described it)5. The spontaneous visual percepts (visual hallucinations) experienced by these patients are identical to those associated with normal seeing, although they can be recognized because of their bizarre and often amusing character and because, given the patients’ impaired vision, they are seen in greater detail than real stimuli6. They differ from visual imagery experiences in that the hallucinations are localized to external space (rather than inside the head), have the vivid qualities of normal seeing and are not under voluntary control. We investigated the neural substrate of visual consciousness in a group of such patients, using two different but complimentary strategies, both of which have proven successful previously7, 8, 9.


The first strategy (Experiment 1) was to ask the patients to signal the onset and offset of each hallucination during a five-minute scan and to then correlate the timing of the hallucinations with the time-course of the fMRI signal. A second, indirect strategy, which did not depend on capturing a hallucination during a scan, identified functionally abnormal brain regions by scanning the patients while they viewed a nonspecific visual stimulus and comparing the results to those of a matched control group who had never experienced hallucinations (Experiment 2).


RESULTS
Visual hallucinations were reported in both experiments. Four patients had spontaneous hallucinations, whereas two others had hallucinations provoked by visual stimulation (Table 1). With the exception of one patient (PP), all hallucinations were in color. Two patients (SH, LC) reported faces, two (FP, PP) reported brickwork, fencing and map textures, and one (AK) reported objects. Unless otherwise stated, all hallucinations occurred in the central visual field. In two patients (AK and FP), Experiment 1 was repeated within the same scanning session to assess response consistency. Three patients (SH, AK, FP) with spontaneous hallucinations were unable to see the stimulus and therefore did not participate in Experiment 2. Therefore, with the exception of one patient (PP), the two experiments had different subjects.


Table 1. The phenomenology and timing of visual hallucinations.
Table 1 thumbnail

Full TableFull Table

Spontaneous hallucinations
In all four patients with spontaneous hallucinations, the fMRI activity that correlated most significantly with the hallucination report was located in the ventral occipital lobe within or around the fusiform gyrus (Fig. 1). Colored hallucinations were associated with activity in the posterior fusiform gyrus (mean x = +28 and −35, y = −81, z = −13), whereas black-and-white hallucinations were associated with activity behind and above this region (x = 30, y = −84, z = −2). The hallucination of a face was associated with activity in the left middle fusiform gyrus (x = −42, y = −57, z = −7.5), hallucinations of objects were associated with activity in the right middle fusiform gyrus (x = 21, y = −66, z = −18), and hallucinations of textures were associated with activity around the collateral sulcus. In some experiments, additional activity was found outside ventral extrastriate cortex (for example, the frontal activation in patient FP or the activity on the medial occipital lobe in SH, shown in Fig. 1); however, this additional activity was neither consistent between repeated experiments in the same patient nor common among different patients. An increase in fMRI signal often preceded a hallucination (for example, the first, fourth and sixth hallucination shown in Fig. 2a). This temporal relationship was found in all patients studied (Fig. 2b).


Figure 1. Spontaneous hallucinations.
Figure 1 thumbnail
Positive correlations between T2*-weighted MRI signal and hallucination report are superimposed (red) on transverse sections of high-resolution structural images (rmax AK, p < 1 times 10−3 ; PP, FP, p < 1 times 10−4; SH, p < 1 times 10−5). The fusiform gyrus has been shaded in blue to aid anatomical localization. The hallucinations are illustrated next to each image. Ventral occipital activity was consistent in repeated experiments on the same patient. The r max was always in the ventral occipital lobe, but the optimal temporal shift varied between patients. No areas had a negative correlation at the same level of significance. In all figures, the left of each structural image is the right of the brain.

Full FigureFull Figure and legend (43K)

Figure 2. The timing of visual hallucinations.
Figure 2 thumbnail
(a) The fMRI time series from the fusiform gyrus (circles) and hallucination log (bars) for patient SH. (b) The mean signal intensity in the 12 seconds before and after the report of hallucination onset. Only hallucinations that occurred after a gap of at least 18 seconds have been included to avoid detecting the signal related to the previous hallucination (n = 13). MR signal has been normalized to the −15 s scan. The increase in signal in the 12 seconds preceding a hallucination is significant (F(4,60) = 3.83; p < 0.01).

Full FigureFull Figure and legend (6K)

Response to visual stimulation
In Experiment 2, in patients with impaired vision who had never hallucinated, the visual stimulus evoked activity along the calcarine fissure (area V1), extending onto the ventral surface of the occipital lobe to include the fusiform gyrus (Fig. 3a). In patients with the Charles Bonnet syndrome, this stimulus evoked activity in the striate cortex but failed to do so in the fusiform and lingual gyri (Fig. 3b). We compared the corrected mean level of fMRI signal (see Methods) within the active ventral extrastriate regions in the controls with the corresponding silent regions in the patients. Mean signal was increased significantly in the hallucinators relative to the controls across the whole five-minute experiment (t = 2.94, df = 8, p < 0.025). The apparent silence of the region was due to a relatively greater increase in signal between the periods of visual stimulation (OFF) than during stimulation (ON), with a consequent degradation of periodic signal (see Methods).


Figure 3. Generic activation to visual stimulation.
Figure 3 thumbnail
Voxels in phase with the stimulus are thresholded at p < 0.05, corrected for multiple comparisons, and superimposed (red) on transverse slices of a template structural image. Talairach z coordinates in mm above and below the AC−PC plane are displayed beneath each column. (a) Control patients. (b) Hallucinators.

Full FigureFull Figure and legend (25K)

 Top

DISCUSSION
Our two sets of results converge on a single conclusion, that hallucinations of color, faces, textures and objects result from increased activity in the ventral occipital lobe. A phasic increase in activity causes a discrete hallucination (Experiment 1), whereas a tonic increase in activity decreases the response to external visual stimulation (Experiment 2). An unexpected finding was the rise in fMRI signal before the onset of the conscious experience, the opposite of the normal delayed response to visual stimulation found in fMRI experiments10, 11. Patients described the appearance and disappearance of their hallucinations as sudden (< 1 s), all-or-nothing phenomena, so the observed ‘reversed’ delay is not an artifact of uncertainty as to when to report the experience. One explanation for this finding might be that cerebral activity must exceed a certain threshold level to contribute to visual consciousness12 and that subthreshold neurophysiological activity starting 15 seconds before the hallucination is responsible for the increase in signal found at −12 seconds.


We found a striking correspondence between the hallucinatory experiences of each patient and the known functional anatomy of the occipital lobe. In patients who hallucinated in color, activity was found in the fusiform gyrus in an area corresponding to the color center, area V4 (mean x = plusminus28, y = −79, z = −16, see Refs 13,14), whereas in the patient who hallucinated in black and white, the activity was outside this region (posterior extent of = −82, max z = −12, see ref 14). The descriptions of featureless colors in the hallucinations are similar to the descriptions given by patients whose ventro-medial occipital cortex has been stimulated directly15. In the patient who hallucinated an unfamiliar face, additional activity was found in the left middle fusiform gyrus, an area that responds to unfamiliar face stimuli (mean x = −35, y = −63, z = −10, see ref 16). In patients who hallucinated brickwork, fences and a map, activity was found around the collateral sulcus, an area that responds to visual textures11. Finally, in the patient who hallucinated objects, activity was found in the middle fusiform gyrus, an area that responds to visually presented objects17,18. These results are, to our knowledge, the first evidence of a correlation between the location of activity within specialized cortex and the contents of a hallucination. 


Visual hallucinations are difficult to dismiss as vivid imagery experiences, as they differ both qualitatively (see Introduction) and, at least for color hallucinations, neurobiologically. (Area V4 was not differentially activated in a color imagery task compared to a spatial-orientation control task19.) The neural substrate of a color hallucination is thus closer to that of a true (non-hallucinated) percept than that of color imagery. The areas identified are unlikely to be related to the motor signaling response of the patients, as this would occur at twice the hallucination frequency (patients signaled both the onset and the offset of each hallucination), and our correlation method would thus be relatively insensitive to it. The complexity of the percepts and the absence of consistent activity in the striate cortex make it unlikely that the ventral occipital lobe is responding to spontaneous discharges in the retina or LGN. Similarly, the absence of consistent activity outside the occipital lobe argues against the hypothesis that activity in the frontal lobe is a prerequisite for conscious vision1,20 or that visual complexity in hallucinations implies activity in the anteriolateral temporal lobe15. However, our data fall short of disproving such theories. If the spatial pattern of ‘higher’ activity is not fixed for a given perceptual experience or is so diffusely distributed that its activity is not reflected in a change in fMRI signal, it would not have been detected by our method. Visual consciousness is presumably the result of complex neuronal processes with top-down influences. The results presented above suggest that such top-down complexity may be localized within each specialized area rather than being distributed across the brain.


We conclude that in patients who are neuropsychiatrically normal and in the absence of afferent sensory input, conscious percepts of color, texture, faces and objects are associated with activity in the ventral extrastriate cortex reflecting the known functional specializations of the region. Why these particular brains are functionally abnormal and whether the abnormality is common to all patients with visual hallucinations will require further investigation. These results complement previous studies of consciousness for motion12, 21and support the hypothesis that processing within each specialized visual area makes a direct contribution to conscious vision22, 23.

 Top

METHODS
Patients and controls.
Eight patients with the Charles Bonnet syndrome (seven male, one female) were selected from a questionnaire-based study of visual hallucinations at the Institute of Psychiatry. Selection was based on (i) the frequency of stereotyped hallucinations (> 1 per day), (ii) the absence of psychiatric illness, epilepsy or cognitive impairment (MMSE > 25, ref. 24) and (iii) suitability for an MRI scan. Control patients who had never hallucinated (five males), matched for age, acuity and visual field defect, were recruited from Kings College and St Thomas’ Hospitals. All patients gave informed consent and were given psychiatric, neurological and ophthalmological assessments.


Spontaneous hallucinations.
The room lights were dimmed, and patients were asked to signal the onset and offset of each hallucination, which was recorded on a computer linked to a hand-held keypad in the scanner. One patient logged the events himself; the remaining three raised or lowered a finger while the event was logged by an investigator. Descriptions of the hallucinations were collected after each scan.


Visual stimulation.
A visual stimulus, consisting of five one-minute cycles of 30 s of visual noise (ON) followed by 30 s of a black screen (OFF), was back-projected onto a translucent screen placed over the end of the scanner bore (elongated semi-circular field, 13° vertical times 27° horizontal). The stimulus contained luminance, color, motion and form across a range of spatial and temporal frequencies. Patients were asked to attend the stimulus and to describe their hallucinations after each scan. No attempt was made to correct refractive errors.


Image Acquisition.
Gradient echo, echoplanar images (EPI) were acquired on a 1.5-Tesla GE Signa System (General Electric, Milwaukee) with an Advanced NMR operating console and quadrature birdcage headcoil for radio frequency transmission and reception. In each experiment, 100 T2*-weighted images depicting blood oxygen level-dependent (BOLD) contrast25 (TR = 3 s; TE = 40 ms) were obtained at each of 14, non-contiguous 7-mm slices (0.7 mm interslice spacing), parallel to the plane passing through the anterior and posterior commissures (AC−PC) and covering the whole brain (in-plane resolution 3 times 3 mm). A high-contrast, high-resolution inversion recovery EPI image (TE = 74 ms; TI = 180 ms; TR = 1600 ms; NEX = 8; voxel size = 1.5 times 1.5 times 3.3 mm) was acquired after the experiments.


Image analysis.
In Experiment 1, the time series were motion corrected26, smoothed in x and y (7-mm full width half maximum (FWHM)) and the coefficient of correlation (r) was calculated at each voxel. The process was repeated after shifting the hallucination log with respect to the fMRI time series in steps of one scan (shifts of −9 s, −6 s, −3 s, 0 s, +3 s, +6 s, +9 s) to optimize r for each patient (r max). Probability maps were calculated from the estimated rmax with 100 degrees of freedom and co-registered with the high-resolution structural image. Talairach27 coordinates were derived from transformed r max images (see below). In Experiment 2, the time series were motion corrected26, and the observed and randomized (10 permutations) fundamental power quotient (FPQ) at 0.016 Hz was estimated at each voxel28. FPQ images were transformed into Talairach space using transformation parameters derived from the structural image29. After smoothing in x and y, (20-mm FWHM), generic activation across patients was computed at each voxel by comparing the median observed FPQ with the median randomized FPQ29. Corrections for multiple comparisons were based on the number of independent voxels after smoothing. The phase of activity was calculated from sine and cosine terms in the regression model. The location of generic activation in the original, non-transformed T2*-weighted images was calculated using the transformation parameters derived above. Mean signal within the ventral occipital region of interest over (i) the whole five-minute experiment, (ii) the ON periods and (iii) the OFF periods was corrected for global intersubject differences in maximum signal across the whole slice.

 Top

Received 22 June 1998; Accepted 24 October 1998


REFERENCES

  1. Crick, F. & Koch, C. Consciousness and neuroscience. Cereb. Cortex 8, 97−107 (1998). | Article | PubMed | ISI | ChemPort |
  2. Kölmel, H. W. Complex visual hallucinations in the hemianopic field. J. Neurol. Neurosurg. Psychiatry 48, 29−38 (1985). | PubMed | ISI |
  3. Lepore, F. E. Spontaneous visual phenomena with visual loss. Neurology 40, 444−447 (1990). | PubMed | ISI | ChemPort |
  4. Holroyd, S. et al. Visual hallucinations in patients with macular degeneration. Am. J. Psychiatry 149, 1701−1706 (1992). | PubMed | ISI | ChemPort |
  5. de Morsier, G. Les automatismes visuels. (Hallucinations visuelles rétrochiasmatiques). Schweiz. Med. Woch. 66, 700−703 (1936).
  6. Teunisse, R. J. et al. Visual hallucinations in psychologically normal people: Charles Bonnet’s syndrome. Lancet 347, 794−797 (1996). | Article | PubMed | ISI | ChemPort |
  7. Howard, R. J. et al. Cortical responses to exogenous visual stimulation during visual hallucinations. Lancet 345, 70 (1995). | Article | PubMed | ISI | ChemPort |
  8. Silbersweig, D. A. et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 378, 176−179 (1995). | Article | PubMed | ISI | ChemPort |
  9. Woodruff, P. W. R. et al. Auditory hallucinations and the temporal cortical response to speech in schizophrenia: A functional magnetic resonance imaging study. Am. J. Psychiatry 154, 1676−1682 (1997). | PubMed | ISI | ChemPort |
  10. Boynton, G. M., Engel, S. A., Glover, G. H. & Heeger, D. J. Linear systems analysis of functional magnetic resonance imaging in human V1. J. Neurosci. 16, 4207−4221 (1996). | PubMed | ISI | ChemPort |
  11. Puce, A. et al. Differential sensitivity of human visual cortex to faces, letterstrings, and textures: a functional magnetic resonance imaging study. J. Neurosci. 16, 5205−5215 (1996). | PubMed | ISI | ChemPort |
  12. Zeki, S. & ffytche, D. H. The Riddoch syndrome: insights into the neurobiology of conscious vision. Brain 121, 25−45 (1998). | Article | PubMed | ISI |
  13. Zeki, S. et al. A direct demonstration of functional specialization in human visual cortex. J. Neurosci. 11, 641−649 (1991). | PubMed | ChemPort |
  14. Mckeefry, D. J. & Zeki, S. The position and topography of the human colour centre as revealed by functional magnetic resonance imaging. Brain 120, 2229−2242 (1997). | Article | PubMed |
  15. Penfield, W. & Rasmussen, T. The Cerebral Cortex of Man (Macmillan, New York, 1950).
  16. Kanwisher, N., McDermott, J. & Chun, M. M. The fusiform face area: a module in human extrastriate cortex specialised for face perception. J. Neurosci. 17, 4302−4311 (1997). | PubMed | ISI | ChemPort |
  17. Sergent, J., Ohta, S. & Macdonald, B. Functional neuroanatomy of face and object processing. Brain 115, 15−36 (1992). | PubMed | ISI |
  18. Kanwisher, N., Chun, M. M., McDermott, J. & Ledden, P. J. Functional imaging of human visual recognition. Cog. Brain Res. 5, 55−67 (1996). | Article | ISI | ChemPort |
  19. Howard, R.J. et al. The functional anatomy of imagining and perceiving colour. Neuroreport 9, 1019−1023 (1998). | PubMed | ISI | ChemPort |
  20. Crick, F. & Koch, C. Are we aware of neural activity in primary visual cortex? Nature375, 121−123 (1995). | Article | PubMed | ISI | ChemPort |
  21. ffytche, D. H., Guy, C. N. & Zeki, S. Motion specific responses from a blind hemifield. Brain 119, 1971−1982 (1996). | PubMed | ISI |
  22. Zeki, S. A Vision of the Brain (Blackwell, Oxford, 1993).
  23. ffytche, D. H. & Zeki, S. Brain activity related to the perception of illusory contours. Neuroimage 3, 104−108 (1996). | Article | PubMed | ISI | ChemPort |
  24. Folstein, M. F., Folstein, S. E. & McHugh, P. R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res.12, 189−198 (1975). | Article | ChemPort |
  25. Kwong, K. K. et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc. Natl. Acad. Sci. USA 89, 5675−5679 (1992). | PubMed | ChemPort |
  26. Friston, K. J. et al. Movement-related effects in fMRI time-series. Magn. Reson. Med.35, 346−355 (1996). | PubMed | ISI | ChemPort |
  27. Talairach, J. & Tournoux, P. Co-planar Stereotaxic Atlas of the Human Brain (Thieme, Stuttgart, 1988).
  28. Bullmore, E. et al. Statistical methods of estimation and inference for functional MR image analysis. Magn. Reson. Med. 35, 261−277 (1996). | PubMed | ISI | ChemPort |
  29. Brammer, M.J. et al. Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach. Magn. Reson. Imaging 15, 763−770 (1997). | Article | PubMed | ISI | ChemPort |
Shopping Cart